SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jack w garnes jr. who wrote (8507)5/26/1998 12:32:00 PM
From: Tim Gardner  Read Replies (2) of 23519
 
Jack, it's people like you that probably run the FDA. Your vision is so short sighted. What you fail to grasp is that Vivus works. Yes, it works and with little or no side effects. Sure everyone right now wants to pop a pill. We live in a drug abusing society as it is. But what happens when Mr. Joe impotent tries out the little pill and his little winky still doesn't respond. Does he run home with his tail between his legs, or does he ask his doctor if there is anything else he can do. Tell me Jack, what would you do if you couldn't get Mr. happy up after trying the so called "miracle drug". Maybe you would give up but would your wife let you. You see Jack, men don't make the decisions when it comes down to it. The old ball and chain does, and what she will do is send Mister Joe impotent back to the office until a treatment is found. Also Jack, Vivus is gaining approval is just about every foreign country we can think of while these same countries are turning their back on the beloved Viagra. So if I were a gambling man -- which I am -- I would have to say that Vivus looks plenty tempting at these levels.

As for Zona -- still a pipe dream -- If you want to pay $35 a share for their stock, I also have a bridge I can sell you.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News